{"type":"profile","id":"profile=medica2026.3083230","exhSeoId":"iuMGhR0cRsyOdndJXk10aw","name":"ImpriMed Korea Co., Ltd","email":"imprimedkorea@imprimedicine.com","getInTouchEmail":"imprimedkorea@imprimedicine.com","profileAddress":{"address":["330, Seongam-Ro, Mapo-gu B-#417, 418"],"city":"Seoul","zip":"03920","country":"Korea, Republic","countryCode":"KR"},"phone":{"phone":"+82 70 40770697"},"links":[{"id":"link=rxETmumNRgetTzgydYzTBw","type":"link","link":"https://www.imprimedicine.com","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[],"locations":[{"areaId":"17","area":"Hall 17","stand":"A04-04"}],"location":"Hall 17 / A04-04","locationIsVirtual":false,"events":[{"key":"medica2026","label":"MEDICA 2026"}],"eventIcons":[{"label":"MEDICA 2026","src":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/medica2026/3083230.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/medica2026/17/3083230.svg","areaId":"17","premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[],"xtags":[],"socialMedia":[],"synonyms":[],"text":"<p>ImpriMed is an AI-driven precision medicine company advancing cancer care, infectious disease diagnostic support, and drug development. We combine artificial intelligence, functional testing, and software as a medical device (SaMD) to deliver actionable insights that help healthcare professionals make informed care decisions and support biopharma partners in developing new therapies.</p>","pdfs":[],"tol":[],"categories":[{"id":"prod=medica2026.02.05.01","label":"Clinical AI & decision support","catalogIndex":"02.05.01","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=Ny63Rvl2Q82ARaNhuPdXQA","label":"NDMM-1: AI-Based Prognostic Risk Stratification for Newly Diagnosed Multiple Myeloma"}],"hierarchy":[{"id":"02","label":"Digital Medicine, Data & Artificial Intelligence"},{"id":"02.05","label":"Artificial intelligence"},{"id":"02.05.01","label":"Clinical AI & decision support"}]}],"write":false,"lastModified":"2026-11-05T01:19:05Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}